NAJAF ASRAR

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NORTH BRUNSWICK, NJ NPI 1104246149

This page merges CMS profile IDs: 4224272, 5702422 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$1,211.88

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 45
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $243.35 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $243.3515

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $193.1612
Xeris Pharmaceuticals, Inc. $50.193

By program year

Program yearAmountRecords
2018 $282.148
2020 $94.391
2021 $15.531
2022 $429.3511
2023 $147.129
2024 $243.3515

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096590363 Novo Nordisk Inc $8.39 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096591420 Novo Nordisk Inc $19.89 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096677810 Novo Nordisk Inc $13.27 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096683097 Novo Nordisk Inc $15.43 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096690931 Novo Nordisk Inc $23.15 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096856288 Novo Nordisk Inc $20.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097044581 Novo Nordisk Inc $18.84 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097093436 Novo Nordisk Inc $20.22 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097218359 Novo Nordisk Inc $19.20 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097520147 Novo Nordisk Inc $11.48 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097563638 Novo Nordisk Inc $5.05 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097664893 Novo Nordisk Inc $18.24 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144607259 Xeris Pharmaceuticals, Inc. $17.89 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144607261 Xeris Pharmaceuticals, Inc. $15.88 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144607263 Xeris Pharmaceuticals, Inc. $16.42 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 4224272, 5702422

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.